Talk Title to be Announced
Courtney H. Lias, PhD
Acting Director, OHT7: Office of in vitro Diagnostic Devices,
United States Food and Drug Administration (FDA)
PLENARY PANEL: Laboratory-Developed Tests:
Proposed Rule, Reclassification Activities, Potential Impact, and Path Forward
MODERATOR:
B. Melina Cimler, PhD, CEO & Founder, PandiaDx LLC
PANELISTS:
Stefan Burde, PhD, Director, Global Strategic Business Development, TÜV SÜD America, Inc.
Girish Putcha, MD, PhD, Principal & Founder, Precision Medicine & Diagnostics
Lakshman Ramamurthy, PhD, Vice President Regulatory Affairs, GRAIL
Anna Scrimenti, Associate Director, Public Policy & Advocacy, Association for Molecular Pathology